MedPath

SEDANA MEDICAL

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:3
Completed:1

Trial Phases

1 Phases

Phase 3:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 3
4 (100.0%)

A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol

Phase 3
Active, not recruiting
Conditions
Post-Intensive Care Syndrome
Sedation
Interventions
Drug: Inhaled isoflurane administered by Sedaconda ACD-S
Drug: Intravenous infusion of propofol
First Posted Date
2025-02-05
Last Posted Date
2025-02-05
Lead Sponsor
Sedana Medical
Target Recruit Count
312
Registration Number
NCT06809218
Locations
🇺🇸

The Critical Illness, Brain Dysfunction and Survivorship (CIBS) Center, Nashville, Tennessee, United States

Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

Phase 3
Active, not recruiting
Conditions
Sedation
Interventions
First Posted Date
2022-04-14
Last Posted Date
2024-06-06
Lead Sponsor
Sedana Medical
Target Recruit Count
235
Registration Number
NCT05327296
Locations
🇺🇸

Memorial Health Services, Long Beach, California, United States

🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

🇺🇸

Stanford University, Redwood City, California, United States

and more 13 locations

Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)

Phase 3
Active, not recruiting
Conditions
Sedation
Interventions
First Posted Date
2022-04-05
Last Posted Date
2024-05-03
Lead Sponsor
Sedana Medical
Target Recruit Count
235
Registration Number
NCT05312385
Locations
🇺🇸

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

and more 11 locations

Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old

Phase 3
Completed
Conditions
Sedation
Interventions
First Posted Date
2020-12-24
Last Posted Date
2025-05-25
Lead Sponsor
Sedana Medical
Target Recruit Count
94
Registration Number
NCT04684238
Locations
🇫🇷

Hôpital Femme-Mère-Enfant Groupe Hospitalier Est, Lyon, France

🇫🇷

CHU de NANTES, Hôpital Mère-Enfant, Nantes, France

🇫🇷

Hôpital Robert-Debré AP-HP, Paris, France

and more 21 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.